Published in J Inorg Biochem on April 28, 2002
Curcumin induces G2/M arrest and apoptosis in cisplatin-resistant human ovarian cancer cells by modulating Akt and p38 MAPK. Cancer Biol Ther (2007) 1.38
Role of glutathione in the regulation of Cisplatin resistance in cancer chemotherapy. Met Based Drugs (2010) 1.25
ST6Gal-I sialyltransferase confers cisplatin resistance in ovarian tumor cells. J Ovarian Res (2013) 0.95
Evidence for different mechanisms of 'unhooking' for melphalan and cisplatin-induced DNA interstrand cross-links in vitro and in clinical acquired resistant tumour samples. BMC Cancer (2012) 0.84
Overexpression of Bcl-2 as a proxy redox stimulus to enhance activity of non-viral redox-responsive delivery vectors. Biomaterials (2008) 0.83
Dysregulation of purine nucleotide biosynthesis pathways modulates cisplatin cytotoxicity in Saccharomyces cerevisiae. Mol Pharmacol (2008) 0.83
Identification of cisplatin-regulated metabolic pathways in pluripotent stem cells. PLoS One (2013) 0.83
Unsymmetric mono- and dinuclear platinum(IV) complexes featuring an ethylene glycol moiety: synthesis, characterization, and biological activity. J Med Chem (2012) 0.82
Dinuclear platinum complexes with N, N'-bis(aminoalkyl)-1,4-diaminoanthraquinones as linking ligands. Part II. Cellular processing in A2780 cisplatin-resistant human ovarian carcinoma cells: new insights into the mechanism of resistance. J Biol Inorg Chem (2004) 0.81
Potentiating effect of UVA irradiation on anticancer activity of Carboplatin derivatives involving 7-azaindoles. PLoS One (2015) 0.80
Mechanisms underlying reductant-induced reactive oxygen species formation by anticancer copper(II) compounds. J Biol Inorg Chem (2011) 0.79
Dinuclear platinum complexes with N, N'-bis(aminoalkyl)-1,4-diaminoanthraquinones as linking ligands. Part I. Synthesis, cytotoxicity, and cellular studies in A2780 human ovarian carcinoma cells. J Biol Inorg Chem (2004) 0.78
Glutathione alleviated peripheral neuropathy in oxaliplatin-treated mice by removing aluminum from dorsal root ganglia. Am J Transl Res (2017) 0.75
DOXIL when combined with Withaferin A (WFA) targets ALDH1 positive cancer stem cells in ovarian cancer. J Cancer Stem Cell Res (2016) 0.75
Combination Platinum-based and DNA Damage Response-targeting Cancer Therapy: Evolution and Future Directions. Curr Med Chem (2016) 0.75
A Rad26-Def1 complex coordinates repair and RNA pol II proteolysis in response to DNA damage. Nature (2002) 1.80
Putting anion-π interactions into perspective. Angew Chem Int Ed Engl (2011) 1.49
Anion binding involving pi-acidic heteroaromatic rings. Acc Chem Res (2007) 1.33
[Fe(mu-btzmp)2(btzmp)2](ClO4)2: a doubly-bridged 1D spin-transition bistetrazole-based polymer showing thermal hysteresis behaviour. Dalton Trans (2007) 1.10
catena-Poly[[dicyanamido(5,5'-dimethyl-2,2'-bipyridine-kappa2N,N')copper(II)]-mu-dicyanamido-kappa2N1:N5]. Acta Crystallogr C (2002) 1.10
A novel isomerization on interaction of antitumor-active azole-bridged dinuclear platinum(II) complexes with 9-ethylguanine. Platinum(II) atom migration from N2 to N3 on 1,2,3-triazole. J Am Chem Soc (2002) 1.09
Unique ligand-based oxidative DNA cleavage by zinc(II) complexes of hpyramol and hpyrimol. Chemistry (2007) 1.07
Structure-dependent in vitro cytotoxicity of the isomeric complexes [Ru(L)2Cl2] (L= o-tolylazopyridine and 4-methyl-2-phenylazopyridine) in comparison to [Ru(azpy)2Cl2]. J Biol Inorg Chem (2004) 1.05
Phenanthroline derivatives with improved selectivity as DNA-targeting anticancer or antimicrobial drugs. ChemMedChem (2008) 1.01
Strongly isolated ferromagnetic layers in poly-trans-mu-dichloro- and poly-trans-mu-dibromobis(1-(2-chloroethyl)-tetrazole-N4)copper(II) complexes. Inorg Chem (2002) 1.01
Activity-based profiling reveals reactivity of the murine thymoproteasome-specific subunit beta5t. Chem Biol (2010) 1.01
Development of an activity-based probe and in silico design reveal highly selective inhibitors for diacylglycerol lipase-α in brain. Angew Chem Int Ed Engl (2013) 1.01
Anticancer drug resistance induced by disruption of the Saccharomyces cerevisiae NPR2 gene: a novel component involved in cisplatin- and doxorubicin-provoked cell kill. Mol Pharmacol (2003) 0.97
An aromatic anion receptor: anion-pi interactions do exist. Angew Chem Int Ed Engl (2004) 0.96
Bis[bis(2-pyridylcarbonyl)aminato]iron(III) perchlorate acetonitrile disolvate. Acta Crystallogr C (2006) 0.95
Synthetic models of the active site of catechol oxidase: mechanistic studies. Chem Soc Rev (2006) 0.94
Copper(II)-catalysed aerobic oxidation of primary alcohols to aldehydes. Chem Commun (Camb) (2003) 0.94
Synthesis, characterization, in vitro antitumor activity, DNA-binding properties and electronic structure (DFT) of the new complex cis-(Cl,Cl)[RuIICl2(NO+)(terpy)]Cl. Dalton Trans (2005) 0.94
Application of fluorescence microscopy for investigation of cellular distribution of dinuclear platinum anticancer drugs. J Med Chem (2005) 0.93
A Mixed-Valence Tetranuclear Copper Cluster with Localized Valencies. Inorg Chem (1997) 0.93
New antitumour active platinum compounds containing carboxylate ligands in trans geometry: synthesis, crystal structure and biological activity. Dalton Trans (2005) 0.93
Ruthenium(III) chloride complex with a tridentate bis(arylimino)pyridine ligand: synthesis, spectra, X-ray structure, 9-ethylguanine binding pattern, and in vitro cytotoxicity. Inorg Chem (2008) 0.91
Altered localisation of the copper efflux transporters ATP7A and ATP7B associated with cisplatin resistance in human ovarian carcinoma cells. BMC Cancer (2008) 0.91
High cytotoxicity of cisplatin nanocapsules in ovarian carcinoma cells depends on uptake by caveolae-mediated endocytosis. Clin Cancer Res (2009) 0.90
2-Chloro-pyrimidin-4-amine. Acta Crystallogr Sect E Struct Rep Online (2012) 0.89
Structure-toxicity relationships for different types of dinuclear platinum complexes. J Inorg Biochem (2006) 0.89
The square-planar cytotoxic [Cu(II)(pyrimol)Cl] complex acts as an efficient DNA cleaver without reductant. J Am Chem Soc (2006) 0.89
Trigonal propeller-shaped [Mn(III)3M(II)Na] complexes (M = Mn, Ca): structural and functional models for the dioxygen evolving centre of PSII. Dalton Trans (2011) 0.89
ZM241385, DPCPX, MRS1706 are inverse agonists with different relative intrinsic efficacies on constitutively active mutants of the human adenosine A2B receptor. J Pharmacol Exp Ther (2006) 0.88
Kinetic study of azole-bridged dinuclear platinum(II) complexes reacting with a hairpin-stabilized double-stranded oligonucleotide. J Inorg Biochem (2003) 0.88
Defective nucleotide excision repair in yeast hpr1 and tho2 mutants. Nucleic Acids Res (2002) 0.87
Citations and ethics. Angew Chem Int Ed Engl (2011) 0.87
Random mutagenesis of the human adenosine A2B receptor followed by growth selection in yeast. Identification of constitutively active and gain of function mutations. Mol Pharmacol (2004) 0.86
The NER protein Rad33 shows functional homology to human Centrin2 and is involved in modification of Rad4. DNA Repair (Amst) (2008) 0.86
Dinuclear platinum anticancer complexes with fluorescent N,N'-bis(aminoalkyl)-1,4-diaminoanthraquinones: cellular processing in two cisplatin-resistant cell lines reflects the differences in their resistance profiles. J Biol Inorg Chem (2005) 0.86
New approach for the preparation of efficient DNA cleaving agents: ditopic copper-platinum complexes based on 3-Clip-Phen and cisplatin. J Med Chem (2007) 0.85
Ruthenium polypyridyl complexes and their modes of interaction with DNA: is there a correlation between these interactions and the antitumor activity of the compounds? J Biol Inorg Chem (2008) 0.84
3-D lanthanide metal-organic frameworks: structure, photoluminescence, and magnetism. Inorg Chem (2009) 0.84
Binding of novel azole-bridged dinuclear platinum(II) anticancer drugs to DNA: insights from hybrid QM/MM molecular dynamics simulations. J Phys Chem B (2006) 0.83
The hydrolysis of the anti-cancer ruthenium complex NAMI-A affects its DNA binding and antimetastatic activity: an NMR evaluation. J Inorg Biochem (2004) 0.83
Rad33, a new factor involved in nucleotide excision repair in Saccharomyces cerevisiae. DNA Repair (Amst) (2006) 0.83
Proteomic identification of in vivo interactors reveals novel function of skin cornification proteins. J Proteome Res (2012) 0.82
The Rad4 homologue YDR314C is essential for strand-specific repair of RNA polymerase I-transcribed rDNA in Saccharomyces cerevisiae. Mol Microbiol (2005) 0.82
Homologous recombination is a highly conserved determinant of the synergistic cytotoxicity between cisplatin and DNA topoisomerase I poisons. Mol Cancer Ther (2004) 0.82
Dinuclear platinum complexes with N, N'-bis(aminoalkyl)-1,4-diaminoanthraquinones as linking ligands. Part II. Cellular processing in A2780 cisplatin-resistant human ovarian carcinoma cells: new insights into the mechanism of resistance. J Biol Inorg Chem (2004) 0.81
Controlled copper-mediated chlorination of phenol rings under mild conditions. Inorg Chem (2007) 0.81
(Aminoethanol)dichloroplatinum(II) complexes: influence of the hydroxyethyl moiety on 5'-GMP and DNA binding, intramolecular stability, the partition coefficient and anticancer activity. J Inorg Biochem (2002) 0.81
Cytotoxic activity and cellular processing in human ovarian carcinoma cell lines of a new platinum(II) compound containing a fluorescent substituted propylene diamine ligand. Biochem Pharmacol (2009) 0.81
Water-soluble platinum(II) complexes of diamine chelating ligands bearing amino-acid type substituents: the effect of the linked amino acid and the diamine chelate ring size on antitumor activity, and interactions with 5'-GMP and DNA. J Inorg Biochem (2004) 0.81
Platinated copper(3-clip-phen) complexes as effective DNA-cleaving and cytotoxic agents. Chemistry (2008) 0.81
Proton NMR spectroscopy and magnetic properties of a solution-stable dicopper(II) complex bearing a single mu-hydroxo bridge. Inorg Chem (2005) 0.81
Crystallographic evidence of nitrate-pi interactions involving the electron-deficient 1,3,5-triazine ring. Inorg Chem (2006) 0.80
Platinum complexes of diaminocarboxylic acids and their ethyl ester derivatives: the effect of the chelate ring size on antitumor activity and interactions with GMP and DNA. J Inorg Biochem (2003) 0.80
Catecholase activity of a copper(II) complex with a macrocyclic ligand: unraveling catalytic mechanisms. Chemistry (2006) 0.80
DNA cleavage and antitumour activity of platinum(II) and copper(II) compounds derived from 4-methyl-2-N-(2-pyridylmethyl)aminophenol: spectroscopic, electrochemical and biological investigation. Dalton Trans (2009) 0.80
New cytotoxic and water-soluble bis(2-phenylazopyridine)ruthenium(II) complexes. J Med Chem (2003) 0.80
A pyrazolato-bridged dinuclear platinum(II) complex induces only minor distortions upon DNA-binding. Chemistry (2006) 0.80
Azole-bridged diplatinum anticancer compounds. Modulating DNA flexibility to escape repair mechanism and avoid cross resistance. J Phys Chem B (2007) 0.80
Unique reactivity of a tetradentate N(2)S(2) complex of nickel: intermediates in the production of sulfur oxygenates. Inorg Chem (2002) 0.79
Cellular accumulation and DNA platination of two new platinum(II) anticancer compounds based on anthracene derivatives as carrier ligands. J Inorg Biochem (2009) 0.79
A copper complex bearing a TEMPO moiety as catalyst for the aerobic oxidation of primary alcohols. Dalton Trans (2008) 0.79
Transcription elongation factor Spt4 mediates loss of phosphorylated RNA polymerase II transcription in response to DNA damage. Nucleic Acids Res (2002) 0.79
Two-step spin-transition iron(III) compound with a wide [high spin-low spin] plateau. Inorg Chem (2009) 0.79
A Unique Mononuclear Nickel Disulfonato Complex Obtained by Oxidation of a Mononuclear Nickel Dithiolate Complex. Inorg Chem (1997) 0.79
Structure, cytotoxicity, and DNA-cleavage properties of the complex [Cu(II)(pbt)Br2]. Inorg Chem (2008) 0.79
Selective copper(II)-mediated oxidative coupling of a nucleophilic reagent to the para-methyl group of 2,4,6-trimethylphenol. Dalton Trans (2005) 0.79
Concurrent anion...pi interactions between a perchlorate ion and two pi-acidic aromatic rings, namely pentafluorophenol and 1,3,5-triazine. Chem Commun (Camb) (2008) 0.78
Repair characteristics and differentiation propensity of long-term cultures of epidermal keratinocytes derived from normal and NER-deficient mice. DNA Repair (Amst) (2005) 0.78
Dichlorobis(2-phenylazopyridine)ruthenium(II) complexes: characterisation, spectroscopic and structural properties of four isomers. Dalton Trans (2004) 0.78
DNA and glutathione interactions in cell-free media of asymmetric platinum(II) complexes cis- and trans-[PtCl2(isopropylamine)(1-methylimidazole)]: relations to their different antitumor effects. J Biol Inorg Chem (2008) 0.78
The beta-glucuronyl-based prodrug strategy allows for its application on beta-glucuronyl-platinum conjugates. Bioorg Med Chem Lett (2004) 0.78
Interaction between the DNA model base 9-ethylguanine and a group of ruthenium polypyridyl complexes: kinetics and conformational temperature dependence. Inorg Chem (2007) 0.78
Dinuclear platinum complexes with N, N'-bis(aminoalkyl)-1,4-diaminoanthraquinones as linking ligands. Part I. Synthesis, cytotoxicity, and cellular studies in A2780 human ovarian carcinoma cells. J Biol Inorg Chem (2004) 0.78
Accurate non-invasive image-based cytotoxicity assays for cultured cells. BMC Biotechnol (2010) 0.78
Automated parallel solid-phase synthesis and anticancer screening of a library of peptide-tethered platinum(II) complexes. J Comb Chem (2003) 0.78
Loss of Hoogsteen pairing ability upon N1 adenine platinum binding. Inorg Chem (2002) 0.78
A two-step spin crossover mononuclear iron(II) complex with a [HS-LS-LS] intermediate phase. Chem Commun (Camb) (2008) 0.78
Probing the potential of platinum(II) complexes for the inhibition of thiol-dependent enzymatic activity. J Inorg Biochem (2005) 0.78
Copper-1,10-phenanthroline complexes binding to DNA: structural predictions from molecular simulations. J Phys Chem B (2009) 0.78
An unusual open cubane structure in a mu(1,1)-azido- and alkoxo-bridged tetranuclear copper(II) complex, [Cu4L2(mu(1,1)-N3)2].5H2O (H3L = N,N'-(2-Hydroxylpropane-1,3-diyl)bis-salicylideneimine). Inorg Chem (2004) 0.78
Monofunctionally trans-diammine platinum(II)-modified peptide nucleic acid oligomers: a new generation of potential antisense drugs. Chemistry (2002) 0.78
Three new asymmetric trans-amine(azole)dichloridoplatinum complexes that overcome cisplatin resistance and their reactions with 5'-GMP. J Inorg Biochem (2006) 0.77
Discrete tetrairon(III) cluster exhibiting a square-planar Fe4(mu4-O) core: structural and magnetic properties. Inorg Chem (2010) 0.77
Efficient [bis(imino)pyridine-iron]-catalyzed oxidation of alkanes. Dalton Trans (2007) 0.77
Synthesis, characterization, and DNA-binding studies of nitro(oligopyridine)ruthenium(II) complexes. Inorg Chem (2006) 0.77
The interaction of peptide-tethered platinum(II) complexes with DNA. J Inorg Biochem (2003) 0.77
Solution structure of the second PDZ domain of the neuronal adaptor X11alpha and its interaction with the C-terminal peptide of the human copper chaperone for superoxide dismutase. J Biomol NMR (2005) 0.77
Novel heteronuclear ruthenium-copper coordination compounds as efficient DNA-cleaving agents. Chem Commun (Camb) (2010) 0.77